Literature DB >> 8480684

Low red blood cell glutathione reductase and pyridoxine phosphate oxidase activities not related to dietary riboflavin: selection by malaria?

B B Anderson1, M Giuberti, G M Perry, G Salsini, I Casadio, C Vullo.   

Abstract

This study was designed to confirm that low dietary riboflavin does not contribute to the flavin-deficient red blood cells commonly found in subjects in Ferrara Province, northern Italy. In this area it is primarily an inherited characteristic believed to have been selected for by malaria, which was endemic from the 12th century. In parallel with assessment of daily riboflavin intake (DRI), flavin adenine dinucleotide-dependent glutathione reductase (EGR) and flavin mononucleotide-dependent pyridoxine phosphate oxidase (PPO) were measured in beta-thalassemic heterozygotes, their normal relatives, and normal spouses (representative of the normal population). In all of these groups there is a high incidence of deficiency of these flavin enzymes. We found that the majority had an adequate riboflavin intake and there was no significant correlation of EGR and PPO activities with DRI. Thus, interpretation of low EGR activity is discussed with reference to studies of EGR done to detect nutritional riboflavin deficiency in countries where there is malnutrition and endemic malaria.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8480684     DOI: 10.1093/ajcn/57.5.666

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  7 in total

1.  Deficiency of two red-cell flavin enzymes in a population in Sardinia: was glutathione reductase deficiency specifically selected for by malaria?

Authors:  B B Anderson; L Corda; G M Perry; D Pilato; M Giuberti; C Vullo
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

2.  Did malaria select for primary adult lactase deficiency?

Authors:  B Anderson; C Vullo
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

3.  Is the flavin-deficient red blood cell common in Maremma, Italy, an important defense against malaria in this area?

Authors:  B B Anderson; M Scattoni; G M Perry; P Galvan; M Giuberti; G Buonocore; C Vullo
Journal:  Am J Hum Genet       Date:  1994-11       Impact factor: 11.025

4.  The Homozygous Hemoglobin EE Variant Is Associated with Poorer Riboflavin Status in Cambodian Women of Reproductive Age.

Authors:  Brock A Williams; Kelsey M Cochrane; Jordie A J Fischer; Abeer M Aljaadi; Liadhan McAnena; Mary Ward; Helene McNulty; Hou Kroeun; Tim J Green; Kyly C Whitfield; Crystal D Karakochuk
Journal:  J Nutr       Date:  2020-07-01       Impact factor: 4.798

5.  An LC-MS/MS-Based Method for the Quantification of Pyridox(am)ine 5'-Phosphate Oxidase Activity in Dried Blood Spots from Patients with Epilepsy.

Authors:  Matthew P Wilson; Emma J Footitt; Apostolos Papandreou; Mari-Liis Uudelepp; Ronit Pressler; Danielle C Stevenson; Camila Gabriel; Mel McSweeney; Matthew Baggot; Derek Burke; Tommy Stödberg; Kate Riney; Manuel Schiff; Simon J R Heales; Kevin A Mills; Paul Gissen; Peter T Clayton; Philippa B Mills
Journal:  Anal Chem       Date:  2017-08-17       Impact factor: 6.986

6.  Inherited glutathione reductase deficiency and Plasmodium falciparum malaria--a case study.

Authors:  Valentina Gallo; Evelin Schwarzer; Stefan Rahlfs; R Heiner Schirmer; Rob van Zwieten; Dirk Roos; Paolo Arese; Katja Becker
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

7.  Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome.

Authors:  Philippa B Mills; Stephane S M Camuzeaux; Emma J Footitt; Kevin A Mills; Paul Gissen; Laura Fisher; Krishna B Das; Sophia M Varadkar; Sameer Zuberi; Robert McWilliam; Tommy Stödberg; Barbara Plecko; Matthias R Baumgartner; Oliver Maier; Sophie Calvert; Kate Riney; Nicole I Wolf; John H Livingston; Pronab Bala; Chantal F Morel; François Feillet; Francesco Raimondi; Ennio Del Giudice; W Kling Chong; Matthew Pitt; Peter T Clayton
Journal:  Brain       Date:  2014-03-18       Impact factor: 13.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.